Black Diamond Therapeutics (NASDAQ:BDTX) Trading Down 1.1% - Here's What HappenedMarket Beat·Jul 17 at 11:40 PMBDTX+1.16%
Biotech and CXO Clinical Momentum: 7 Core Companies Set for Late-2026 BreakoutsGlobal Report·Jul 9 at 05:02 AMBVS+3.17%ALT+4.90%
Black Diamond Therapeutics holds annual stockholder meeting via webcastPUBT·Jun 29 at 03:21 PMBDTX+1.16%
Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA PathMarket Beat·Jun 6 at 04:04 AMBDTX+1.16%
What's Going On With Black Diamond Therapeutics Stock Tuesday?benzinga_article·May 26 at 10:31 AMBDTX+1.16%PBE+0.64%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·May 22 at 12:05 PMAKTX-0.71%NGEN-0.61%
Black Diamond Plunges Despite Positive Phase 2 Results For Silevertinib In 1L NSCLCnasdaq·May 22 at 03:20 AMBDTX+1.16%IBB+1.38%
U.S. Stock Movement Update: Workday rises over 10%, Black Diamond Therapeutics falls nearly 11%Price Alert·May 21 at 09:00 PMWDAY+4.13%BDTX+1.16%
U.S. Stock Movement Update: Workday rises 11.42%, Black Diamond Therapeutics falls 13.80% attracting attentionPrice Alert·May 21 at 08:00 PMWDAY+4.13%BDTX+1.16%
Black Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 StudyMarket Beat·May 21 at 06:09 PMBDTX+1.16%IXJ+2.54%
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations | BDTX Stock NewsStockTitan·May 21 at 08:15 AMBDTX+1.16%LABU-0.78%
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watchrttnews·May 20 at 04:04 AMADIL-2.14%BDTX+1.16%
